Evaluating the Performance of Anal Cytology and Human Papillomavirus Testing for Detection of Anal Cancer and Pre‐Cancerous Lesions
Diagnostic Cytopathology · 2026-08 · 54 (8) · 597-609
DOI: 10.1002/dc.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic Cytopathology, online erschienen am 14.05.2026. Verfasst von Sheldon Russell und 2 weiteren Autor:innen. Beteiligte Einrichtung: PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Anus Neoplasms, Human Papillomavirus Viruses, Papillomavirus Infections, Carcinoma, Squamous Cell. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
Anal squamous cell carcinoma (SCC) incidence is rising; however, anal cancer screening guidelines require further refinement. This study evaluated the accuracy of anal cytology and human papilloma virus (HPV) testing for anal cancer screening in our pathology service, identifying limitations of these tests when applied to this role.
Methods
Pathology records of all 240 patients who had undergone anal or perianal biopsy during 2023 were evaluated. Reports for 1364 smears, 817 biopsy procedures, and 1441 HPV tests conducted on these patients between 2002 and 2024 were reviewed.
Results
The cohort included 413 biopsy diagnoses of high‐grade squamous intraepithelial lesion (HSIL) and 8 of anal SCC. Using 406 smears conducted on the same day as biopsy, cytology demonstrated a high sensitivity (86.3%) but poor specificity (31.9%) for identification of high‐grade lesions if a cytological diagnosis of possible low‐grade SIL (pLSIL) or worse was the criterion to proceed to biopsy (International Anal Neoplasia Society (IANS) guidelines). Specific examination of limitations of cytology included poorer detection of anal intraepithelial neoplasia 2 (AIN2) and AIN2/3 lesions ( p < 0.001), where surface epithelial maturation and keratinisation may obscure sampling of dysplastic cells. Of 6 patients diagnosed with high‐grade lesions but testing negative for high‐risk HPV, re‐testing using the paraffin‐embedded biopsy tissue detected HPV16 in 4.
Conclusions
Anal cytology and HPV testing perform important and complementary roles in the context of anal cancer screening, but each is associated with technical limitations. While the sensitivity of testing is excellent, improvements in specificity are required to prevent unnecessary biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Sheldon Russell, Jacqueline Bentel, Andrew Laycock
Zitieren
APA
Russell, S., Bentel, J., & Laycock, A. (2026). Evaluating the Performance of Anal Cytology and Human Papillomavirus Testing for Detection of Anal Cancer and Pre‐Cancerous Lesions. Diagnostic Cytopathology, 54(8), 597-609. https://doi.org/10.1002/dc.70144
Vancouver
Russell S, Bentel J, Laycock A. Evaluating the Performance of Anal Cytology and Human Papillomavirus Testing for Detection of Anal Cancer and Pre‐Cancerous Lesions. Diagnostic Cytopathology. 2026;54(8):597-609. doi:10.1002/dc.70144
BibTeX
@article{Russell2026,
author = {Russell, Sheldon and Bentel, Jacqueline and Laycock, Andrew},
title = {Evaluating the Performance of Anal Cytology and Human Papillomavirus Testing for Detection of Anal Cancer and Pre‐Cancerous Lesions},
journal = {Diagnostic Cytopathology},
year = {2026},
volume = {54},
number = {8},
pages = {597--609},
doi = {10.1002/dc.70144}
}
EUVIMED